AARD vs BROS · $284.4M cap vs P/E 105, rev $1.02B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Dutch Bros Inc (BROS) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
AARD currently screens at market cap $284.4M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Not investment advice. Open the AARD and BROS stock pages for the full models.
Not investment advice.